Realizing that immune checkpoint molecules are also involved in immune paralysis following severe systemic inflammatory responses (28), or persistent infections due to sustained local immune suppressions (29), PD-1 or PD-L1 targeting antibodies are currently investigated to overcome immune suppression in prolonged or severe infections (11, 12). This evidence concerns the gene PDCD1 and infection.